Alberto Salazar, the US distance coach who led Mo Farah to four Olympic gold medals and six world titles, has reportedly lost his appeal against a string of doping violations.
Salazar had sworn to clear his name after being sanctioned in October 2019 and appealed to the Court of Arbitration for Sport. But after a virtual hearing that lasted for seven days in March, his sanction was upheld and, as a result, he will have to serve his full four-year suspension. Cas’s detailed explanation for his decision is expected shortly.
Jeffrey Brown, who worked as a paid consulting endocrinologist for Nike on performance improvement and was a doctor for many Salazar athletes, also lost his appeal against a four-year ban.
Project Oregon was originally set up to help American endurance athletes beat the best African runners, but then recruited several top athletes, including Farah and Sifan Hassan, from around the world.
However, a 2015 BBC and ProPublic investigation based on Project Oregon whistleblowers, including assistant coach Steve Magness and world 10,000m medalist Kara Goucher, raised questions about his methods and led to an official investigation of Salazar by the US Anti-. Doping agency.
In 2019, the 63-year-old was recognized by an arbitration panel for trafficking testosterone, a banned performance-enhancing substance, administering a banned intravenous infusion and tampering with or attempting to tamper with the doping control process athletes.
However, Salazar has never been convicted of doping his athletes. Neither Farah, who left the Oregon Project in 2017, nor Hassan have been charged with doping.
In 2019, Usada CEO Travis Tygart said: “The athletes in these cases have found the courage to speak out and have finally exposed the truth. Working with the Nike Oregon Project, Salazar and Dr. Brown demonstrated that winning is more important than the health and well-being of athletes.
However, the same year, Salazar protested his innocence, saying he was “shocked” by the outcome. “My athletes and I have suffered unfair, unethical and very damaging treatment from Usada.”